Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Research Scholar, Gurukul Kangri, Deemed to be University, Haridwar, India

Mrs. Shalini Singh 🌸 is a highly accomplished scientific writer and researcher specializing in phytopharmacology 🌿, herbal medicine 🌼, and integrative therapeutics πŸ§ͺ. With a Master’s in Pharmacology πŸŽ“ and currently pursuing her Ph.D. 🎯 at Gurukula Kangri University, Haridwar, she has made outstanding contributions to academic and regulatory scientific writing πŸ“š. She worked at Patanjali Research Foundation 🌱 from 2018-2022, authoring numerous high-impact peer-reviewed articles, monographs, and dossiers. Mrs. Singh has collaborated with multidisciplinary teams πŸ‘©β€πŸ”¬, contributed to national and international initiatives like NMCG and AYUSH 🌍, and reviewed for top journals like Elsevier and Springer πŸ“. Her work bridges traditional wisdom and modern science, embodying excellence 🌟, dedication πŸ’ͺ, and innovation πŸ’‘. She continues to inspire through her research, scientific integrity, and pursuit of holistic healthcare solutions 🌏.

Publication Profile

Orcid

Experience

Mrs. Singh is a skilled Scientific Writer πŸ–‹οΈ who worked at Patanjali Research Foundation, Haridwar (May 2018–Nov 2022), where she authored peer-reviewed articles πŸ“„, pharmacological monographs πŸ“‘, systematic reviews πŸ“š, and regulatory documents πŸ›οΈ. She specialized in herbal medicine 🌿, clinical data analysis πŸ“Š, and scientific dossier preparation, demonstrating a strong command over both scientific detail and regulatory standards. Earlier, she served as an Assistant Professor πŸŽ“ at Lords International College of Pharmacy, Alwar (Dec 2017–April 2018), engaging in teaching πŸ“š, mentoring students 🎯, curriculum development ✍️, and academic research πŸ§ͺ. Throughout her career, Mrs. Singh collaborated with interdisciplinary teams 🀝, reviewed manuscripts for leading journals πŸ“°, and contributed to national projects initiated by the Ministry of AYUSH and the NMCG 🌐. Her work consistently reflects a unique blend of scientific rigor πŸ”¬, exceptional communication skills πŸ—£οΈ, and regulatory precision πŸ“, establishing her as an invaluable asset to the research community.

Awards and Honors

Mrs. Shalini Singh exemplifies academic excellence πŸ“š, leadership πŸ…, and a deep commitment to advancing healthcare research and Ayurvedic sciences 🌿. As a dedicated peer reviewer πŸ–ŠοΈ for prestigious journals like Elsevier, Springer, Wiley, Bentham Science, and Frontiers 🌍, she actively contributes to the scientific community. She has participated 🎀 in multiple national and international conferences 🌏, including “Modernization of Traditional Indian Medicine” 🌱, “Emerging Scenario of Science, Technology & Innovation-2023” πŸ”¬, and “Plants to Patients – Series 3: Rethinking Ethnopharmacology” 🌸. Her scholarly engagements extend further with her successful completion πŸ† of the DST-Sponsored STUTI Training Program at SATHI-BHU, Varanasi πŸŽ“. Mrs. Singh’s numerous participations, invited talks, and reviewer roles highlight her dynamic presence in the academic world, showcasing her drive to foster innovation and interdisciplinary collaboration. Her work continues to impact the fields of ethnopharmacology and traditional medicine, inspiring future researchers and practitioners alike 🌟.

Research Focus

Mrs. Shalini Singh’s research centers around phytopharmacology 🌱, herbal medicine 🌿, ethnopharmacology 🧬, and integrative therapeutics πŸ’Š. She has explored the anti-diabetic 🌟, anti-inflammatory πŸ§ͺ, and wound healing 🩹 potentials of natural products and traditional herbs. Her interest extends to modernizing Ayurvedic treatments πŸ§˜β€β™€οΈ through evidence-based studies, clinical evaluation πŸ“Š, and data synthesis from ethnobotanical sources πŸ“š. She has worked on national and global projects 🌏, authoring scientific dossiers, monographs, and manuscripts that bridge the gap between traditional medicine and contemporary healthcare practices 🧠. In addition to primary research, she emphasizes scientific communication πŸ–‹οΈ, regulatory documentation πŸ“‘, and the development of novel therapeutics πŸš€, making her a key player in promoting holistic, sustainable healthcare innovation 🌼.

Publication Top Notes

Research Articles:

  • πŸ“„ Evaluation of Anti-Diabetic activity of fruits of Withania coagulans in streptozotocin-induced diabetic rats.

  • πŸ“„ Anti-Hyperglycemic activity of Pithecellobium dules plant extracts on blood glucose levels of streptozotocin-induced diabetic rats.

  • πŸ“„ Effectiveness of Ayurvedic Regimens in Managing Polycystic Ovarian Syndrome and Related Comorbidities: An Observational Study.

  • πŸ“„ Exploring the Role of Herbo-mineral Combinations for the Management of Hypothyroidism.

  • πŸ“„ Elevating the Inner-Consciousness β€œThird Eye” Through β€œVedic Manas Yoga” Practice.

  • πŸ“„ Effect of various extracts from Ficus retusa L. stem bark on wound healing potential.

Review Articles:

  • πŸ“š Ayurvedic Approaches to Managing Premature Greying of Hair: A Comprehensive Review.

  • πŸ“š Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms.

  • πŸ“š Nature’s Signature in Ayurveda with an Ethnopharmacological Approach: A Narrative Review.

  • πŸ“š Nanotechnology in the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Scoping Analysis.

  • πŸ“š Impact of Biosensors and Biomarkers in Diabetes Care: A Review.

  • πŸ“š Swertia chirayita (Roxb.) H. Karst.: A Magnificent Natural Remedy for Gastrointestinal Disorders.

  • πŸ“š Effect of Coliform Bacteria on Various Environmental Factors: A Review.

  • πŸ“š Hazardous Consequences and Management of Heavy Metals in Sewage Sludge: An Overview.

  • πŸ“š Withania coagulans Dunal.: A Narrative Review of an Anti-diabetic Shrub of the Desert Biome.

  • πŸ“š Bartogenic Acid: A Promising Pentacyclic Triterpenoid in Cancer Research and Possible Mechanism.

 

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences πŸ§ πŸ”¬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 πŸŽ“πŸ‡¨πŸ‡³. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery πŸ₯🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 πŸŽ“πŸ”. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery πŸ“š. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being β€οΈβ€πŸ©Ή.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital πŸ₯. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery πŸ‘¨β€βš•οΈ. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University πŸŽ“. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease πŸ“šπŸ”¬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) πŸ§‘β€πŸ”¬πŸ…. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) πŸ‡¨πŸ‡³πŸ”. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) πŸ’‘πŸ”¬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes πŸ§ͺπŸ“Š. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions πŸ’ŠπŸ§ πŸ§‘β€βš•οΈ.

Publication Top Notes

 

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications πŸ“„ and supervised doctoral candidates πŸŽ“, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors πŸ₯. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology πŸ”¬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes πŸ₯.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology πŸ… from the University Hospital of DΓΌsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology πŸ“– from the University of DΓΌsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice πŸ§ͺ. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of DΓΌsseldorf (1983). His expertise in cancer biology, virology, and molecular research πŸ“Š has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine πŸ”¬πŸ’Š. He is currently a Senior Postdoctoral Fellow at the Institut National de la SantΓ© et de la Recherche MΓ©dicale, University of Strasbourg, France (2018-2025) πŸ₯. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) πŸŽ“, and a Postdoctoral Fellow at the University Hospital of DΓΌsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion πŸ₯, and targeting cancer stem-like cells to enhance treatment efficacy πŸ’Š. He investigates the role of non-receptor tyrosine kinases in oncogenesis πŸ”¬ and explores immune checkpoint inhibitors and their associated cutaneous adverse effects βš•οΈ. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes